Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Pandoraon Feb 19, 2022 1:43pm
314 Views
Post# 34445068

New patent approval

New patent approval
This is one I was not following but it was approved February 8, 2022

Select New Case Application Data Transaction History Image File Wrapper Patent Term Adjustment History Continuity Data Fees Published Documents Correspondence Data Assignments Display Download References
 Transaction History
Application Is Considered Ready for Issue
Date Transaction Description
02-08-2022 Recordation of Patent Grant Mailed
01-21-2022 Email Notification
01-19-2022 Issue Notification Mailed
02-08-2022 Patent Issue Date Used in PTA Calculation
12-29-2021 Email Notification
12-28-2021 Dispatch to FDC
12-28-2021  
15/289,574 FIBER OPTIC LIGHT DELIVERY, MONITORING AND APPARATUS THEREFOR T1081/20041 Printer Friendly Version


 Bibliographic Data
Application Number: 15/289,574 Correspondence Address Customer Number: 3000
Filing or 371 (c) Date: 10-10-2016 Status: Publications -- Issue Fee Payment Verified
Application Type: Utility Status Date: 12-28-2021
Examiner Name: HUH, VYNN V Location: What is a Location? ELECTRONIC
Group Art Unit: 3792 Location Date: -
Confirmation Number: 4587 Earliest Publication No: US 2017-0100606 A1
Attorney Docket Number: T1081/20041 Earliest Publication Date: 04-13-2017
Class / Subclass: 607/088 Patent Number: 11,241,587
First Named Inventor: Lothar LILGE , Toronto, (CA) all Inventors Issue Date of Patent: 02-08-2022
First Named Applicant: Theralase Technologies, Inc. , Toronto, (CA) all Applicants International Registration Number (Hague): -
Entity Status: Small International Registration Publication Date: -
AIA (First Inventor to File): Yes
<< Previous
Bullboard Posts
Next >>